Enhertu Brings New Hope for HER2-Positive Tumors: What You Should Know
At Learn Look Locate, we believe in the power of hope, community, and knowledge.
Earlier this year, the FDA approved Enhertu (fam-trastuzumab deruxtecan-nxki), a groundbreaking therapy that continues to offer renewed hope for those with HER2-positive solid tumors. This breakthrough treatment has already made a significant impact on the lives of many patients.
This approval is a game-changer in cancer treatment, making Enhertu the first therapy that can be used across any HER2-positive tumor, no matter where it occurs in the body. For many, this brings a ray of hope, especially for those with limited treatment options.
Why Enhertu Is a Breakthrough
Enhertu’s approval for tumors with strong HER2 protein expression (IHC 3+) opens up a world of possibilities. Patients who previously had few choices can now access targeted treatment that focuses on the specific biology of their cancer.
To learn more about how HER2-positive cancers are treated, explore our guide to HER2-targeted therapies.
Managing Side Effects with Care
While Enhertu is a beacon of hope, we understand that managing side effects may feel overwhelming. Thankfully, there are effective ways to reduce these effects. Nausea, for example, is common, but many patients find relief with medications like Zofran.
For more advice, visit our guide on managing breast cancer treatment options here.
You might also experience fatigue, mild hair thinning, or changes in blood counts, but with the support of your healthcare team, these side effects are often manageable.
For inspiration, read about Kari’s resilience through her battle with Stage 2 Invasive Ductal Carcinoma in her survivor story.
Keeping an Eye on Pneumonitis
It’s important to stay vigilant about pneumonitis, a lung condition that may affect some patients. With the right care, risks can be managed effectively. Be sure to communicate any changes in breathing or a persistent cough with your doctor.
Learn more about how clinical trials are advancing treatments and improving outcomes in our clinical trials section.
A Journey of Hope and Possibility
Enhertu represents a new beginning for many, bringing hope and the promise of effective treatments. Staying informed and empowered is key to making the best decisions for your care. Understanding your HER2 status through genomic testing can help guide your treatment plan—discover the role of genomic testing in treatment planning.
At Learn Look Locate, we’re here to support you every step of the way. For more detailed information and personal stories from women who have navigated their own journeys, visit our community at Learn Look Locate. Together, we can move forward with strength, resilience, and hope.